[LXRX] YoY Quarter Result on 30-Sep-2015 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
09-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- -25.68%
YoY- 12.88%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 6,856 26,942 27,717 566 419 238 372 62.48%
PBT -27,512 -30,722 -36,015 -35,282 -40,498 -31,658 -29,539 -1.17%
Tax 783 2,034 1,135 1,627 205 503 -576 -
NP -27,512 -30,722 -36,015 -35,282 -40,498 -31,658 -29,539 -1.17%
Tax Rate - - - - - - - -
Total Cost 34,368 57,664 63,732 35,848 40,917 31,896 29,911 2.34%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin -401.28 -114.03 -129.94 -6,233.57 -9,665.39 -13,301.68 -7,940.59 -39.18%
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
EPS -0.26 -0.29 -0.35 -0.34 -0.55 -0.43 -0.42 -7.67%
EPS Diluted -0.26 -0.29 -0.35 -0.34 -0.55 -0.43 -0.42 -7.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.